Phase I trial of yttrium-90-HuM195 (anti-CD33) in myeloid leukemia: Potential for myeloablation Meeting Abstract
| Authors: | Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Hamacher, K. A.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A. |
| Abstract Title: | Phase I trial of yttrium-90-HuM195 (anti-CD33) in myeloid leukemia: Potential for myeloablation |
| Meeting Title: | 8th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer |
| Keywords: | leukemia; lymphoma; clinical radioimmunotherapy; meeting abstract |
| Journal Title: | Cancer Biotherapy and Radiopharmaceuticals |
| Volume: | 15 |
| Issue: | 4 |
| Meeting Dates: | 2000 Oct 12-14 |
| Meeting Location: | Princeton, NJ |
| ISSN: | 1084-9785 |
| Publisher: | Mary Ann Liebert, Inc |
| Date Published: | 2000-08-01 |
| Start Page: | 408 |
| Language: | English |
| ACCESSION: | BCI:BCI200000508760 |
| PROVIDER: | biosis |
| PUBMED: | 11198631 |
| DOI: | 10.1089/cbr.2000.15.407 |
| Notes: | Meeting abstract: 39 -- Source: Biosis |
Altmetric
Citation Impact
BMJ Impact Analytics
